Compound information
- Natural Products
- ZC270789
- Molecular Formula
- C13H14O4
- Molecular Weight
- 234.089208928 g/mol
- Structure
-
- IUPAC Name
- (E)-6-(4-hydroxy-3-methoxy-phenyl)hex-5-ene-2,4-dione
- InChI
- InChI=1S/C13H14O4/c1-9(14)7-11(15)5-3-10-4-6-12(16)13(8-10)17-2/h3-6,8,16H,7H2,1-2H3/b5-3+
- InChI Key
- SQDOMQCCCHMXBP-HWKANZROSA-N
- SMILES
- COc1cc(/C=C/C(=O)CC(C)=O)ccc1O
- Source
- ZINC000034581303
Warheads
- Carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 17 | Ring Count | 1 |
Heteroatom Count | 4 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 63.6 Å2 | LogP | 1.466 |
LogS | -2.607 | LogD | 1.649 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.08 | Pgp substrate | 0.002 |
HIA | 0.962 | F20 % | 0.991 |
F30 % | 0.971 | Caco-2 | -4.606 |
MDCK | -4.803 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.488 | PPB | 86.078 |
VD | 0.354 | Fu | 0.758 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.17 | CYP1A2 substrate | 0.482 |
CYP2A6 substrate | 0.505 | CYP2B6 substrate | 0.59 |
CYP2C19 inhibitor | 0.012 | CYP2C19 substrate | 0.718 |
CYP2C8 substrate | 0.71 | CYP2C9 inhibitor | 0.065 |
CYP2C9 substrate | 0.389 | CYP2D6 inhibitor | 0.003 |
CYP2D6 substrate | 0.378 | CYP2E1 substrate | 0.19 |
CYP3A4 inhibitor | 0.021 | CYP3A4 substrate | 0.025 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.958 | CL | 14.896 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.001 | Hepatotoxicity | 0.981 |
Mutagenicity | 0.023 | Rat Oral Acute Toxicity | 0.142 |
FDAMDD | 0.178 | Skin Sensitization | 0.97 |
Carcinogenicity | 0.802 | Eye Corrosion | 0.952 |
Eye Irritation | 0.983 | Respiratory Toxicity | 0.82 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.811 | IGC50 | 4.828 |
LC50FM | 5.044 | LC50DM | 4.308 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.251 | NR-AR-LBD | 0.531 |
NR-AhR | 0.115 | NR-Aromatase | 0.043 |
NR-ER | 0.699 | NR-ER-LBD | 0.421 |
NR-PPAR-gamma | 0.908 | SR-ARE | 0.095 |
SR-ATAD5 | 0.825 | SR-HSE | 0.142 |
SR-MMP | 0.064 | SR-p53 | 0.139 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.